Assoc. Prof. Dr. Semiha Solak Grassie is an Associate Professor of Infectious Diseases and Clinical Microbiology based in Ankara, Turkey. She earned her medical degree from Çukurova University Faculty of Medicine and completed her residency in Clinical Bacteriology and Infectious Diseases at Ankara University Faculty of Medicine. Throughout her career, Assoc. Prof. Dr. Solak Grassie has served at premier healthcare institutions, including Yenimahalle Training and Research Hospital. Her clinical leadership and research focus heavily on hospital epidemiology, infection prevention and control, antimicrobial resistance, and occupational infection risks among healthcare personnel. An active scholar, Assoc. Prof. Dr. Solak Grassie has contributed significantly to international peer-reviewed medical literature. Her recent high-impact publications explore hospital outbreak containment, COVID-19 contact tracing and geriatric outcomes, emerging resistant pathogens such as Candida auris in intensive care units, and longitudinal trends in carbapenem resistance in home healthcare settings. She remains dedicated to advancing clinical standards, hospital safety, and evidence-based infection management.
Assoc. Prof. Dr. Semiha Solak Grassie is an Associate Professor of Infectious Diseases and Clinical Microbiology based in Ankara, Turkey. She earned her medical degree from Çukurova University Faculty of Medicine and completed her residency in Clinical Bacteriology and Infectious Diseases at Ankara University Faculty of Medicine. Throughout her career, Assoc. Prof. Dr. Solak Grassie has served at premier healthcare institutions, including Yenimahalle Training and Research Hospital. Her clinical leadership and research focus heavily on hospital epidemiology, infection prevention and control, antimicrobial resistance, and occupational infection risks among healthcare personnel. An active scholar, Assoc. Prof. Dr. Solak Grassie has contributed significantly to international peer-reviewed medical literature. Her recent high-impact publications explore hospital outbreak containment, COVID-19 contact tracing and geriatric outcomes, emerging resistant pathogens such as Candida auris in intensive care units, and longitudinal trends in carbapenem resistance in home healthcare settings. She remains dedicated to advancing clinical standards, hospital safety, and evidence-based infection management.